HOME >> BIOLOGY >> NEWS
Livermore research team wins distinguished Department of Energy award for development of miniature glucose sensor for diabetes patients

ght Award is selected by a panel of DOE Citizen Judges, who choose innovations from among 23 discoveries or innovations hatched between 1999 and 2000. The innovations must demonstrate a benefit to the American public, be a contribution to U.S. competitiveness in the global marketplace and have the potential for significant future growth.

"We are extremely proud that DOE has selected one of the extraordinary achievements made by the Laboratory's Medical Technology Program team for the Bright Light Award," said Jeff Wadsworth, deputy director for Science and Technology. "This award proves the Laboratory continues to make significant contributions that benefit the quality of life."

The Bright Light Award is part of DOEs Energy 100 list, which honors 23 years of the best scientific and technological accomplishments the Department of Energy has to offer since the department was created in 1977. The achievements were nominated for review by DOE lab, program and field offices. A panel of citizen judges evaluated the achievements based on consumer orientation, whether it saves money and its ability to improve American quality of life.


'"/>

Contact: Anne Stark
stark8@llnl.gov
925-422-9799
DOE/Lawrence Livermore National Laboratory
7-Jan-2001


Page: 1 2

Related biology news :

1. Livermore research in accelerator mass spectrometry highlighted at ACS meeting
2. Livermore & NIH scientists create technique to examine behavior of proteins at single molecule level
3. Livermore researchers apply combat simulation technology to homeland security
4. NNSAs Livermore Lab partners with cities and counties to track biological, chemical releases
5. Lawrence Livermore research team finds unique DNA signatures to improve anthrax detection
6. Livermore Lab hosts conference on Bioterrorism for the Courts
7. Lawrence Livermore Lab, UC Davis Cancer Center ink alliance to develop integrated cancer program
8. UC Davis and Lawrence Livermore National Laboratory seek industry partners to develop new bio and medical technology products
9. Leader in cancer treatment and prevention research honored
10. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
11. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories

Post Your Comments:
(Date:2/13/2015)... , Feb. 13, 2015 ACT ... company that aims to transform cancer genomic information ... that the company has raised US$ 8 million in ... Based in Taipei, Taiwan , ... ACTDrug™, ACTOnco™. With the aim to implement next ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
(Date:2/28/2015)... 2015 Increasing its efforts to resolve the ... first three episodes of The GMO TRUTH podcast on both ... as it continues its mission to discover the truth and ... phase, to “uncover the truth about the GMOs in our ... GMO Truth Podcast is an expansion of the documentary/investigative film-making ...
(Date:2/27/2015)... Calif. , Feb. 27, 2015  Pharmacyclics, ... that longer-term toxicology studies for its newly developed ... or RA, have been completed. The results of ... U.S. Food and Drug Administration. The feedback received ... of the ongoing first-in-human study. Additional preclinical work ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... clinical stage vaccine and immunotherapy company, today announced ... approved its application for Fast Track designation and ... DPX-Ebola vaccines, in conjunction with the mutual co-development ... had previously obtained Fast Track designation for the ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:The Walk a Mile Project Launches “GMO Truth” Podcast 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3
Cached News: